Product Information
AMOX-CLAV 400-57 MG/5 ML SUSP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0839 per ML under NDC 00143998250. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jan 25, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400; 57 mg/5mL; mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143998250
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMOXICILLIN; CLAVULANIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA065191FDA Approved
1/25/2005
TE Code
AB
On Market Since
12/1/2007
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 44.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0839 per ML |
|---|---|
| All-time high | $0.1722 (Dec 14, 2016) |
| All-time low | $0.0630 (Jul 19, 2023) |
| 52-week high | $0.0854 |
| 52-week low | $0.0776 |
| Median price | $0.0988 |
| Average price | $0.1069 |
| Largest weekly change | +43.7% (Aug 23, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMOX-CLAV 400-57 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 400-57 MG/5 ML SUSP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0839 per ML (NDC 00143998250), effective Aug 19, 2026.
How has the price of AMOX-CLAV 400-57 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has declined 44.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 400-57 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has ranged from a low of $0.0630 (Jul 19, 2023) to a high of $0.1722 (Dec 14, 2016), with a median of $0.0988 per ML.
Are there cheaper alternatives to AMOX-CLAV 400-57 MG/5 ML SUSP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOX-CLAV 400-57 MG/5 ML SUSP, is $0.0567 per ML — about 32% below AMOX-CLAV 400-57 MG/5 ML SUSP.
Who manufactures AMOX-CLAV 400-57 MG/5 ML SUSP?
AMOX-CLAV 400-57 MG/5 ML SUSP (NDC 00143998250) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.